The Food and Drug Administration has updated information on the ongoing leucovorin shortage as of 3/23/09.
Both Bedford Laboratories and Teva Pharmaceuticals are reporting manufacturing delays for leucovorin. Spectrum Pharmaceuticals has limited supplies of Fusilev® (levoleucovorin) which is a different formulation. Fusilev dosages are not equal to leucovorin doses and need to be used with care. Read the rest of this entry »